Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.38 -0.20 (-7.40%)
As of: Nov 11, 2026 · 3:06 PM EST

Galmed Pharmaceuticals (EOCN) Price to Sales (2017 - 2023)

Updated

Galmed Pharmaceuticals' Price to Sales came in at 87.29 for Q2 2019, down 44.9% from 158.33 a year earlier.

Analysis

Galmed Pharmaceuticals (EOCN) Price to Sales (2017 - 2023) Analysis & Trends

For FY2018, Galmed Pharmaceuticals' Price to Sales was 70.44, down 42.1% from FY2017.

  • Going back by year, Price to Sales was 121.74 in FY2017 (+33.3%) and 91.31 in FY2016.
  • The five-year range for quarterly Price to Sales is 70.44 (Q4 2018) to 158.33 (Q2 2018).
  • Year-over-year, Price to Sales increased in 1 of the last five quarters, with an average decline of 0.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Galmed Pharmaceuticals 2.06 Mn -38.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 3,798.30
Mar 31, 2022 8,886.52
Mar 31, 2020 18,336.50
Jun 30, 2019 13,917.93
Mar 31, 2019 13,628.93
Dec 31, 2018 12,679.42
Sep 30, 2018 15,261.81
Jun 30, 2018 28,497.80
Mar 31, 2018 13,338.89
Dec 31, 2017 21,912.17
Sep 30, 2017 18,422.03
Jun 30, 2017 13,493.26
Mar 31, 2017 14,549.32
API Access

Galmed Pharmaceuticals Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=EOCN&period=max&api_key=YOUR_API_KEY